The value of molecular genetic methods in the current diagnosis of lymphoproliferative diseases is estimated. A standardized BIOMED2 protocol for these studies is described. The merits and demerits of this method are considered.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!